Price
$118.28
Increased by +1.09%
Dollar volume (20D)
281.82 M
ADR%
2.03
Earnings report date
Jan 30, 2025
Shares float
240.78 M
Shares short
4.78 M [1.99%]
Shares outstanding
242.01 M
Market cap
28.32 B
Beta
0.62
Price/earnings
22.50
20D range
114.60 126.23
50D range
106.98 126.23
200D range
92.74 126.23

Cardinal Health, Inc. operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally.

It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.

The company operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution.

It distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products, as well as medical supplies.

The company also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; offers pharmacy management services to hospitals; operates pharmacies, including pharmacies in community health centers; and repackages generic pharmaceuticals and over-the-counter healthcare products.

In addition, it manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compression solution, incontinence, nutritional delivery, and wound care products; single-use surgical drapes, gowns, and apparel products; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines.

Further, the company distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits.

Additionally, it manufactures, prepares, delivers, and distributes radiopharmaceuticals and related treatments; and optimizes direct shipments through integrated technology solutions.

The company was incorporated in 1979 and is headquartered in Dublin, Ohio.

  • Quarterly earnings
  • Annual earnings
Reported date EPSChange YoY EstimateSurprise
Nov 1, 24 1.88
Increased by +8.67%
1.62
Increased by +16.05%
Aug 14, 24 1.84
Increased by +18.71%
1.73
Increased by +6.36%
May 2, 24 2.08
Increased by +19.54%
1.95
Increased by +6.67%
Feb 1, 24 1.82
Increased by +37.88%
1.60
Increased by +13.75%
Nov 3, 23 1.73
Increased by +44.17%
1.40
Increased by +23.57%
Aug 15, 23 1.55
Increased by +47.62%
1.49
Increased by +4.03%
May 4, 23 1.74
Increased by +20.00%
1.49
Increased by +16.78%
Feb 2, 23 1.32
Increased by +3.94%
1.14
Increased by +15.79%
  • Quarterly financials
  • Annual financials
Fiscal ending date RevenueChange YoY IncomeChange YoY ProfitChange YoY
Sep 30, 24 52.28 B
Decreased by -4.54%
416.00 M
Increased by +8.22 K%
Increased by +0.80%
Increased by +8.62 K%
Jun 30, 24 59.87 B
Increased by +12.00%
236.00 M
Increased by +468.75%
Increased by +0.39%
Increased by +429.24%
Mar 31, 24 54.91 B
Increased by +8.76%
258.00 M
Decreased by -25.22%
Increased by +0.47%
Decreased by -31.24%
Dec 31, 23 57.45 B
Increased by +11.61%
353.00 M
Increased by +371.54%
Increased by +0.61%
Increased by +343.29%
Sep 30, 23 54.76 B
Increased by +10.40%
5.00 M
Decreased by -95.45%
Increased by +0.01%
Decreased by -95.88%
Jun 30, 23 53.45 B
Increased by +13.48%
-64.00 M
Decreased by -146.38%
Decreased by -0.12%
Decreased by -140.87%
Mar 31, 23 50.49 B
Increased by +12.60%
345.00 M
Increased by +124.82%
Increased by +0.68%
Increased by +122.04%
Dec 31, 22 51.47 B
Increased by +13.23%
-130.00 M
Decreased by -365.31%
Decreased by -0.25%
Decreased by -334.32%
Open dropdown content
Open dropdown content
DAILY
WEEKLY
MONTHLY